Advisor OS’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,177
Closed -$599K 638
2025
Q4
$599K Sell
2,177
-297
-12% -$81.2K 0.05% 257
2025
Q3
$649K Sell
2,474
-345
-12% -$83.8K 0.06% 215
2025
Q2
$617K Sell
2,819
-18
-0.6% -$3.85K 0.06% 220
2025
Q1
$635K Buy
2,837
+559
+25% +$154K 0.07% 194
2024
Q4
$746K Sell
2,278
-569
-20% -$179K 0.09% 157
2024
Q3
$855K Sell
2,847
-171
-6% -$52.4K 0.09% 180
2024
Q2
$994K Buy
3,018
+221
+8% +$78.1K 0.11% 163
2024
Q1
$1.11M Buy
2,797
+453
+19% +$168K 0.13% 149
2023
Q4
$825K Sell
2,344
-628
-21% -$222K 0.11% 166
2023
Q3
$1.12M Buy
2,972
+114
+4% +$44.1K 0.17% 116
2023
Q2
$1.09M Buy
2,858
+29
+1% +$10.4K 0.18% 113
2023
Q1
$980K Buy
2,829
+114
+4% +$33.3K 0.24% 109
2022
Q4
$639K Buy
2,715
+488
+22% +$116K 0.17% 133
2022
Q3
$549K Sell
2,227
-440
-16% -$134K 0.17% 123
2022
Q2
$806K Sell
2,667
-407
-13% -$132K 0.24% 100
2022
Q1
$1.26M Sell
3,074
-1,851
-38% -$725K 0.37% 63
2021
Q4
$2.31M Buy
4,925
+220
+5% +$94.7K 0.47% 58
2021
Q3
$2M Sell
4,705
-193
-4% -$81.4K 0.43% 52
2021
Q2
$1.76M Buy
4,898
+433
+10% +$143K 0.37% 51
2021
Q1
$1.26M Buy
4,465
+586
+15% +$168K 0.29% 65
2020
Q4
$1.1M Buy
3,879
+1,214
+46% +$341K 0.29% 49
2020
Q3
$733K Buy
2,665
+1,693
+174% +$448K 0.31% 38
2020
Q2
$221K Buy
+972
New +$191K 0.13% 121

Other funds holding WST